Microglial activation and traumatic brain injury.

Traumatic brain injury induces macrophage subsets in the brain. Eur J Immunol (2013) 1.06

Late exercise reduces neuroinflammation and cognitive dysfunction after traumatic brain injury. Neurobiol Dis (2013) 0.96

Chronic neurodegeneration after traumatic brain injury: Alzheimer disease, chronic traumatic encephalopathy, or persistent neuroinflammation? Neurotherapeutics (2015) 0.94

Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury. Br J Pharmacol (2015) 0.83

Single administration of tripeptide α-MSH(11-13) attenuates brain damage by reduced inflammation and apoptosis after experimental traumatic brain injury in mice. PLoS One (2013) 0.82

The Effects of Shilajit on Brain Edema, Intracranial Pressure and Neurologic Outcomes following the Traumatic Brain Injury in Rat. Iran J Basic Med Sci (2013) 0.80

Concussive injury before or after controlled cortical impact exacerbates histopathology and functional outcome in a mixed traumatic brain injury model in mice. J Neurotrauma (2013) 0.78

Cell cycle inhibition reduces inflammatory responses, neuronal loss, and cognitive deficits induced by hypobaria exposure following traumatic brain injury. J Neuroinflammation (2016) 0.75

Regulatory T cells exhibit neuroprotective effect in a mouse model of traumatic brain injury. Mol Med Rep (2016) 0.75

Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol (2011) 3.42

Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci (2010) 2.40

Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Natl Acad Sci U S A (2005) 2.10

Gene profiling in spinal cord injury shows role of cell cycle in neuronal death. Ann Neurol (2003) 2.06

Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Nat Med (2009) 1.95

Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. CNS Drug Rev (2006) 1.86

Cell cycle activation contributes to post-mitotic cell death and secondary damage after spinal cord injury. Brain (2007) 1.56

Cell death mechanisms and modulation in traumatic brain injury. Neurotherapeutics (2010) 1.54

The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration. EMBO J (2006) 1.54

Propofol limits microglial activation after experimental brain trauma through inhibition of nicotinamide adenine dinucleotide phosphate oxidase. Anesthesiology (2013) 1.49

Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states. Neurobiol Aging (2012) 1.41

Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma. J Cereb Blood Flow Metab (2008) 1.41

Role of the cell cycle in the pathobiology of central nervous system trauma. Cell Cycle (2005) 1.32

Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury. J Neuroinflammation (2012) 1.31

Progressive neurodegeneration after experimental brain trauma: association with chronic microglial activation. J Neuropathol Exp Neurol (2014) 1.29

Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity. Glia (2009) 1.28

BOK and NOXA are essential mediators of p53-dependent apoptosis. J Biol Chem (2004) 1.25

Gene expression profile changes are commonly modulated across models and species after traumatic brain injury. J Neurotrauma (2003) 1.25

The pathobiology of moderate diffuse traumatic brain injury as identified using a new experimental model of injury in rats. Neurobiol Dis (2004) 1.21

Role of cell cycle proteins in CNS injury. Neurochem Res (2007) 1.21

Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3beta, and induction of the mitochondrial-dependent intrinsic caspase pathway. Mol Cell Neurosci (2003) 1.20

In vivo and in vitro characterization of novel neuronal plasticity factors identified following spinal cord injury. J Biol Chem (2004) 1.20

Gene expression profiling of experimental traumatic spinal cord injury as a function of distance from impact site and injury severity. Physiol Genomics (2005) 1.19

Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma. J Cereb Blood Flow Metab (2011) 1.19

Caspase inhibitor z-DEVD-fmk attenuates calpain and necrotic cell death in vitro and after traumatic brain injury. J Cereb Blood Flow Metab (2004) 1.16

Activation of metabotropic glutamate receptor 5 modulates microglial reactivity and neurotoxicity by inhibiting NADPH oxidase. J Biol Chem (2009) 1.15

Expression of two temporally distinct microglia-related gene clusters after spinal cord injury. Glia (2006) 1.14

Ceramide induces neuronal apoptosis through mitogen-activated protein kinases and causes release of multiple mitochondrial proteins. Mol Cell Neurosci (2005) 1.14

Neuronal plasticity after spinal cord injury: identification of a gene cluster driving neurite outgrowth. FASEB J (2004) 1.09

Multiple caspases are activated after traumatic brain injury: evidence for involvement in functional outcome. J Neurotrauma (2002) 1.07

Over-expression of HSP70 attenuates caspase-dependent and caspase-independent pathways and inhibits neuronal apoptosis. J Neurochem (2012) 1.07

Cell cycle activation and CNS injury. Neurotox Res (2009) 1.06

Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurotherapeutics (2009) 1.05

Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors. Br J Pharmacol (2005) 1.05

A combined scoring method to assess behavioral recovery after mouse spinal cord injury. Neurosci Res (2010) 1.04

MGLuR5 activation reduces beta-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor. J Neurochem (2004) 1.04

Activation of metabotropic glutamate receptor 5 improves recovery after spinal cord injury in rodents. Ann Neurol (2009) 1.04

Comparing the predictive value of multiple cognitive, affective, and motor tasks after rodent traumatic brain injury. J Neurotrauma (2012) 1.04

Delayed expression of cell cycle proteins contributes to astroglial scar formation and chronic inflammation after rat spinal cord contusion. J Neuroinflammation (2012) 1.02

CR8, a selective and potent CDK inhibitor, provides neuroprotection in experimental traumatic brain injury. Neurotherapeutics (2012) 1.02

Delayed inflammatory mRNA and protein expression after spinal cord injury. J Neuroinflammation (2011) 1.01

Fluid-percussion-induced traumatic brain injury model in rats. Nat Protoc (2010) 1.00

Characterization of inflammatory gene expression and galectin-3 function after spinal cord injury in mice. Brain Res (2012) 0.98

Neuropathological differences between rats and mice after spinal cord injury. J Magn Reson Imaging (2010) 0.98

Modulation of ABCA1 by an LXR agonist reduces β-amyloid levels and improves outcome after traumatic brain injury. J Neurotrauma (2011) 0.98

Cell cycle activation and spinal cord injury. Neurotherapeutics (2011) 0.97

Neuronal and glial mGluR5 modulation prevents stretch-induced enhancement of NMDA receptor current. Pharmacol Biochem Behav (2002) 0.97

Impaired autophagy flux is associated with neuronal cell death after traumatic brain injury. Autophagy (2014) 0.96

Multifunctional drug treatment in neurotrauma. Neurotherapeutics (2009) 0.96

Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies. NeuroRx (2004) 0.96

Cyclin D1 gene ablation confers neuroprotection in traumatic brain injury. J Neurotrauma (2012) 0.96

Late exercise reduces neuroinflammation and cognitive dysfunction after traumatic brain injury. Neurobiol Dis (2013) 0.96

Activation of mGluR5 and inhibition of NADPH oxidase improves functional recovery after traumatic brain injury. J Neurotrauma (2013) 0.95

Inhibition of E2F1/CDK1 pathway attenuates neuronal apoptosis in vitro and confers neuroprotection after spinal cord injury in vivo. PLoS One (2012) 0.95

Ceramide-induced cell death in primary neuronal cultures: upregulation of ceramide levels during neuronal apoptosis. J Neurosci Res (2002) 0.93

TrkB.T1 contributes to neuropathic pain after spinal cord injury through regulation of cell cycle pathways. J Neurosci (2013) 0.91

Delayed cell cycle pathway modulation facilitates recovery after spinal cord injury. Cell Cycle (2012) 0.90

Neuroprotective effects of selective group II mGluR activation in brain trauma and traumatic neuronal injury. J Neurotrauma (2006) 0.89

Isolated spinal cord contusion in rats induces chronic brain neuroinflammation, neurodegeneration, and cognitive impairment. Involvement of cell cycle activation. Cell Cycle (2014) 0.88

Ceramide induces neuronal apoptosis through the caspase-9/caspase-3 pathway. Biochem Biophys Res Commun (2002) 0.88

Pathophysiological response to experimental diffuse brain trauma differs as a function of developmental age. Dev Neurosci (2010) 0.88

Novel mGluR5 positive allosteric modulator improves functional recovery, attenuates neurodegeneration, and alters microglial polarization after experimental traumatic brain injury. Neurotherapeutics (2014) 0.87

Combined inhibition of cell death induced by apoptosis inducing factor and caspases provides additive neuroprotection in experimental traumatic brain injury. Neurobiol Dis (2012) 0.86

Cell cycle activation contributes to increased neuronal activity in the posterior thalamic nucleus and associated chronic hyperesthesia after rat spinal cord contusion. Neurotherapeutics (2013) 0.86

PARP-1 inhibition attenuates neuronal loss, microglia activation and neurological deficits after traumatic brain injury. J Neurotrauma (2014) 0.85

Metabotropic glutamate receptor-mediated signaling in neuroglia. Wiley Interdiscip Rev Membr Transp Signal (2012) 0.84

The "dark side" of endocannabinoids: a neurotoxic role for anandamide. J Cereb Blood Flow Metab (2004) 0.84

Modulation of metabotropic glutamate receptors as potential treatment for acute and chronic neurodegenerative disorders. Drug News Perspect (2003) 0.83

Synthesis and biological activity of novel neuroprotective diketopiperazines. Bioorg Med Chem (2002) 0.82

Cell cycle inhibition limits development and maintenance of neuropathic pain following spinal cord injury. Pain (2016) 0.82

Neuroprotective effects of geranylgeranylacetone in experimental traumatic brain injury. J Cereb Blood Flow Metab (2013) 0.82

Modulation of stretch-induced enhancement of neuronal NMDA receptor current by mGluR1 depends upon presence of glia. J Neurotrauma (2003) 0.81

Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain. J Neurotrauma (2008) 0.80

Chronic decrease in wakefulness and disruption of sleep-wake behavior after experimental traumatic brain injury. J Neurotrauma (2014) 0.79

Estimation of ligand efficacies of metabotropic glutamate receptors from conformational forces obtained from molecular dynamics simulations. J Chem Inf Model (2013) 0.78

Changing the name of the journal. NeuroRx (2006) 0.75

Transitions and transformations. Neurotherapeutics (2011) 0.75